Singapore: European Commission has approved Janssen-Cilag International's Stelara (ustekinumab), as a stand-alone drug o...
Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announc...
Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process ...
Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...
Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of ac...
Singapore: AB SCIEX, life science analytical technologies provider, has launched StatusScope Remote Monitoring service, ...
Singapore: Global supplier firm, Agilent Technologies, has launched QuikChange HT Protein Engineering System, a novel sy...
Singapore: As a solution to the lack of affordable test tube baby technology in developing countries, Belgian doctors ha...
Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclo...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Singapore: Serological tests conducted on poultry workers of southern Guangdong province city of Shenzhen China, showed ...
Singapore: San Francisco-based Ascendancy Healthcare has tied up with Quintiles to get help from the contract research g...
Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep...
Singapore: India based Polyclone, a biotech company with expertise in molecular, cell and computational biology has coll...
Singapore: GE Healthcare introduced KUBio, an innovative off-the-shelf, modular factory, designed to save manufacturers ...
Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thail...
Singapore: Novozymes reported seven percent sales growth in 2012 when compared with 2011. EBIT increased by 17 percent, ...
